Efforts for Expedited Process to Get Medical Marijuana Lauded in Nevada
- LEGALITIES, MEDICAL MARIJUANA, NEWS
- June 22, 2016

Georgia’s tightly controlled medical marijuana program is poised for a major expansion after Gov. Brian Kemp signed Senate Bill 220 into law, with changes taking effect July 1. The measure removes previous caps on THC levels in medical cannabis products and will allow additional forms, including flower and vape cartridges, to be sold to registered
READ MORE
Indiana State Sen. Mike Bohacek is preparing 2027 legislation that would legalize medical marijuana, citing shifting federal policy and growing openness from Gov. Mike Braun. The proposal follows the Trump administration’s move to reclassify state-licensed medical marijuana as a less-restricted Schedule III drug, a change that recognizes its medical use under federal law. Bohacek’s measure
READ MORE
The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that
READ MORE
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE
The U.S. Department of Justice has ordered looser federal regulation of state-legal medical marijuana, in what advocates are calling a “historic” shift in federal drug policy. Under an order signed by acting Attorney General Todd Blanche, many cannabis products will move from Schedule I, the government’s strictest drug category, to Schedule III, aligning them with
READ MORE
A new survey of more than 3,500 patients suggests medical cannabis could significantly reduce reliance on traditional prescription drugs, including opioids, sleeping aids and antidepressants. The study, conducted by German telehealth firm Bloomwell, found patients reduced their use of medications by an average of 84.5 percent after starting medical marijuana, with nearly 59 percent stopping
READ MORE